A2 Vertaisarvioitu katsausartikkeli tieteellisessä lehdessä
Pleiotropic Effects of Secretin: A Potential Drug Candidate in the Treatment of Obesity?
Tekijät: Laurila Sanna, Rebelos Eleni, Honka Miikka-Juhani, Nuutila Pirjo
Kustantaja: Frontiers in Endocrinology
Julkaisuvuosi: 2021
Journal: Frontiers in Endocrinology
Lehden akronyymi: Front. Endocrinol.
Vuosikerta: 12
DOI: https://doi.org/10.3389/fendo.2021.737686
Verkko-osoite: https://www.frontiersin.org/article/10.3389/fendo.2021.737686
Rinnakkaistallenteen osoite: https://research.utu.fi/converis/portal/detail/Publication/67265386
Secretin is the first hormone that has been discovered, inaugurating the era and the field of endocrinology. Despite the initial focus, the interest in its actions faded away over the decades. However, there is mounting evidence regarding the pleiotropic beneficial effects of secretin on whole-body homeostasis. In this review, we discuss the evidence from preclinical and clinical studies based on which secretin may have a role in the treatment of obesity.
Ladattava julkaisu This is an electronic reprint of the original article. |